一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> European Heart Journal Supplements >>article
European Heart Journal Supplements

European Heart Journal Supplements

IF: 1.7
Download PDF

Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies.

Published:6 October 2020 DOI: 10.1093/eurheartj/suaa117 PMID: 33061866
Brian Olshansky,?Mina K Chung,?Matthew J Budoff,?Sephy Philip,?Lixia Jiao,?Ralph T Doyle,?Christina Copland,?Alex Giaquinto,?Rebecca A Juliano,?Deepak L Bhatt

Abstract

Mineral oil is often used as a clinical trial placebo. Pharmaceutical-grade mineral oil consists of a mixture of saturated hydrocarbons, with a purity and chemical structure that differs substantially from food-grade or technical-/industrial-grade mineral oils. Interest in mineral oil was piqued by suggestions that a portion of the substantially positive results of the Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial (REDUCE-IT) might be attributable to the theoretical negative effects of mineral oil rather than being due to the clinical benefits of icosapent ethyl. The objective of this review was to explore possible mineral oil safety and efficacy effects and contextualize these findings in light of the REDUCE-IT conclusions. A literature search identified studies employing mineral oil placebos. Eighty studies were identified and relevant data extracted. Adverse events associated with mineral oil were generally gastrointestinal and consistent with use as a lubricant laxative. Changes in triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and other biomarkers were inconsistent and generally not statistically significant, or clinically meaningful with mineral oil, as were changes in blood pressure. There was no consistent evidence that mineral oil in the amounts used in the REDUCE-IT or Effect of Vascepa on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy (EVAPORATE) trials affects absorption of essential nutrients or drugs, including statins. These results were then considered alongside publicly available data from REDUCE-IT. Based on available evidence, mineral oil does not appear to impact medication absorption or efficacy, or related clinical outcomes, and, therefore, does not meaningfully affect study conclusions when used as a placebo at the quantities used in clinical trials.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Mineral oil 8042-47-5 N/A 524 suppliers $20.90-$2780.00
EPA 25378-27-2 C20H30O2 59 suppliers $29.00-$558.00

Similar articles

IF:5.7

Mineral oil in food, cosmetic products, and in products regulated by other legislations.

Critical Reviews in Toxicology Ralph Pirow, Annegret Blume,etc Published: 1 October 2019
IF:3

The use and safety of doxycycline hyclate and other second-generation tetracyclines.

Expert Opinion on Drug Safety Barry Sloan, Noah Scheinfeld,etc Published: 1 September 2008
仲巴县| 萨迦县| 石嘴山市| 潮州市| 兰州市| 穆棱市| 外汇| 炉霍县| 山丹县| 海丰县| 浏阳市| 即墨市| 曲水县| 延津县| 隆昌县| 南郑县| 西华县| 丹棱县| 灵石县| 珲春市| 习水县| 色达县| 肥城市| 玉树县| 克什克腾旗| 东山县| 沛县| 荣成市| 亳州市| 高尔夫| 莱州市| 仙桃市| 郑州市| 陆丰市| 遵化市| 枣庄市| 灵武市| 榆林市| 婺源县| 社会| 庆云县|